Enorama Pharma
4,81 SEK -3,8%Vær den første som følger denne virksomhed
Enorama Pharma is a pharmaceutical company. The company's operations are focused on producing and developing medical nicotine chewing gum. The products are mainly sold through retailers who sell the product under their own brand. The largest market is established in the Nordic region, but also worldwide. Enorama Pharma was founded in 2006 and the head office is located in Malmö.
Omsætning
-
EBIT %
-
P/E
-
Udbytteafkast, %
-
Kursmål
-
Anbefaling
-
Opdateret
-
First North Stockholm
ERMA
Daglig lav / høj pris
4,62 / 5,1
SEK
Markedsværdi
290,88 mio. SEK
Aktieomsætning
333,34 t SEK
Volumen
70 t
Finanskalender
Delårsrapport
20.11.2024
Årsrapport
19.02.2025
Større aktionærerKilde: Millistream Market Data AB
Ejer | Kapital | Stemmer |
---|---|---|
madHat AB | 23,5 % | 23,5 % |
DS Group Singapore | 17,1 % | 17,1 % |
Premium
This content is for our Premium customers only.